4.7 Article

Multivariate classification of patients with Alzheimer's and dementia with Lewy bodies using high-dimensional cortical thickness measurements: an MRI surface-based morphometric study

期刊

JOURNAL OF NEUROLOGY
卷 260, 期 4, 页码 1104-1115

出版社

SPRINGER HEIDELBERG
DOI: 10.1007/s00415-012-6768-z

关键词

Alzheimer's disease; Dementia with Lewy bodies; Surface-based morphometry; Multivariate classification; Computer-assisted diagnosis

资金

  1. Western Norway Regional Health Authority
  2. Norwegian Research Council
  3. MedIm (Norwegian University of Science and Technology, Trondheim)
  4. Slovenian Research Agency

向作者/读者索取更多资源

Alzheimer's disease (AD) and dementia with Lewy bodies (DLB) are the most common neurodegenerative dementia types. It is important to differentiate between them because of the differences in prognosis and treatment approaches. Investigate if sparse partial least squares (SPLS) classification of cortical thickness measurements could differentiate between AD and DLB. Two independent cohorts without MR-protocol alignment in Norway and Slovenia with 97 AD and DLB subjects were enrolled. Cortical thickness measurements acquired with Freesurfer were used in subsequent SPLS classification runs. The cohorts were analyzed separately and afterwards combined. The models were trained with leave-one-out cross validation and test datasets where used when available. To study the impact of MR-protocol alignment, the classifiers were additionally tested on sets drawn exclusively from the independent cohorts. The obtained sensitivity/specificity/AUC values were 94.4/88.89/0.978 and 88.2/94.1/0.969 in the Norwegian and Slovenian cohorts, respectively. Both cohorts showed AD-associated pattern of thinning in mid-anterior temporal, occipital and subgenual cingulate cortex, whereas the pattern supportive for DLB included thinning in dorsal cingulate, posterior temporal and lateral orbitofrontal regions. When combining the cohorts, sensitivity/specificity/AUC were 82.1/85.7/0.948 for the training and 77.8/75/0.731 for the testing datasets with the same pattern-of-difference. The models tested on datasets drawn exclusively from the independent cohorts did not produce adequate accuracy. SPLS classification of cortical thickness is a good method for differentiating between AD and DLB, relatively stable even for mixed data, but not when tested on completely independent data drawn from different cohorts (without MR-protocol alignment).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Cholinergic white matter pathways along the Alzheimer's disease continuum

Milan Nemy, Martin Dyrba, Frederic Brosseron, Katharina Buerger, Peter Dechent, Laura Dobisch, Michael Ewers, Klaus Fliessbach, Wenzel Glanz, Doreen Goerss, Michael T. Heneka, Stefan Hetzer, Enise I. Incesoy, Daniel Janowitz, Ingo Kilimann, Christoph Laske, Franziska Maier, Matthias H. Munk, Robert Perneczky, Oliver Peters, Lukas Preis, Josef Priller, Boris-Stephan Rauchmann, Sandra Roeske, Nina Roy, Klaus Scheffler, Anja Schneider, Bjorn H. Schott, Annika Spottke, Eike J. Spruth, Michael Wagner, Jens Wiltfang, Renat Yakupov, Maria Eriksdotter, Eric Westman, Olga Stepankova, Lenka Vyslouzilova, Emrah Duezel, Frank Jessen, Stefan J. Teipel, Daniel Ferreira

Summary: Nemy et al. investigate cholinergic white matter projections along the Alzheimer's disease continuum, finding that alterations in these pathways are present in individuals with subjective cognitive decline. These alterations precede the more widespread changes seen in mild cognitive impairment and Alzheimer's disease dementia. The study highlights the potential of using cholinergic white matter pathways as markers for the early stages of Alzheimer's disease.
Review Clinical Neurology

(Dis-)Connected Dots in Dementia with Lewy Bodies-A Systematic Review of Connectivity Studies

Annegret Habich, Lars-Olof Wahlund, Eric Westman, Thomas Dierks, Daniel Ferreira

Summary: This systematic review summarizes findings on the structural and functional brain connectivity in patients with dementia with Lewy bodies (DLB). DLB patients show widespread abnormalities within and across brain networks, which are associated with core clinical features and cognitive impairments. Graph theoretical measures reveal disease-related decreases in local and global network efficiency. These connectivity characteristics may be particularly valuable at early stages of DLB and can help improve diagnosis, prognosis, and identify targets for future treatment.

MOVEMENT DISORDERS (2023)

Article Clinical Neurology

Social Health and Cognitive Change in Old Age: Role of Brain Reserve

Anna Marseglia, Gregoria Kalpouzos, Erika J. Laukka, Jane Maddock, Praveetha Patalay, Hui-Xin Wang, Lars Backman, Eric Westman, Anna-Karin Welmer, Serhiy Dekhtyar

Summary: This study investigates the interplay between social health and brain structural properties in relation to cognitive change in older adults. The findings suggest that both good social health and larger brain volume are associated with slower cognitive decline. Furthermore, good social health is related to higher cognitive levels in individuals with larger brain volume.

ANNALS OF NEUROLOGY (2023)

Article Behavioral Sciences

The cognitive profile of middle-aged and older adults with high vs. low autistic traits

Gavin R. Stewart, Anne Corbett, Clive Ballard, Byron Creese, Dag Aarsland, Adam Hampshire, Helen Brooker, Rebecca A. Charlton, Francesca Happe

Summary: Cognitive differences in memory, information processing speed, and executive functions are common in autistic and high autistic trait populations. Older adults with high autistic traits experience more difficulties in memory, IPS, and EF tasks compared to those with low autistic traits. Further research is needed to examine age-related changes in cognitive profiles of older adults with autism traits.

AUTISM RESEARCH (2023)

Review Geriatrics & Gerontology

Implications of Adverse Outcomes Associated with Antipsychotics in Older Patients with Dementia: A 2011-2022 Update

Marianna Rogowska, Mary Thornton, Byron Creese, Latha Velayudhan, Dag Aarsland, Clive Ballard, Konstantinos Tsamakis, Robert Stewart, Christoph Mueller

Summary: Neuropsychiatric symptoms are common in patients with dementia and can lead to distress, rapid disease progression, and higher mortality. Non-pharmacological management should be the first-line treatment, but if medications are necessary, second-generation antipsychotics are commonly used. However, antipsychotic use in dementia is associated with adverse outcomes such as increased mortality, pneumonia, and cerebrovascular events. The risks are influenced by various factors, making individualized treatment decisions challenging. Close monitoring and early withdrawal of pharmacotherapy when possible can help mitigate these risks.

DRUGS & AGING (2023)

Article Neurosciences

Fast three-dimensional image generation for healthy brain aging using diffeomorphic registration

Jingru Fu, Antonios Tzortzakakis, Jose Barroso, Eric Westman, Daniel Ferreira, Rodrigo Moreno

Summary: Predicting brain aging is important for early detection and prognosis of neurodegenerative diseases. This paper proposes a methodology to fill missing data in longitudinal cohorts with anatomically plausible images. The proposed methodology uses deep learning-based diffeomorphic registration to simulate the aging process and rearrange the generated images to specific age ranges. The experimental results show that this methodology can produce anatomically plausible aging predictions and enhance longitudinal datasets.

HUMAN BRAIN MAPPING (2023)

Article Clinical Neurology

Associations between dietary patterns and dementia-related neuroimaging markers

Jessica Samuelsson, Anna Marseglia, Olof Lindberg, Eric Westman, Joana B. Pereira, Sara Shams, Silke Kern, Felicia Ahlner, Elisabet Rothenberg, Ingmar Skoog, Anna Zettergren

Summary: This study found associations between dietary patterns and dementia-related neuroimaging markers. Specifically, a high-protein and alcohol pattern was negatively associated with cortical thickness, while a Mediterranean-like pattern was positively associated with white matter microstructural integrity. No associations were found with a Western-like pattern.

ALZHEIMERS & DEMENTIA (2023)

Article Neurosciences

The Association Between Temporal Atrophy and Episodic Memory Is Moderated by Education in a Multi-Center Memory Clinic Sample

Mans Gyllenhammar, Anna Rennie, Daniel Ferreira Padilla, John Wallert, Anders Rydstrom, Lars-Olof Wahlund, Maria Eriksdotter, Eric Westman, Urban Ekman

Summary: Education level is associated with atrophy in the medial temporal lobe and memory, with education moderating the effect of atrophy on memory.

JOURNAL OF ALZHEIMERS DISEASE (2023)

Article Behavioral Sciences

Grey matter volume loss in Parkinson's disease psychosis and its relationship with serotonergic gene expression: A meta-analysis

Sara Pisani, Brandon Gunasekera, Yining Lu, Miriam Vignando, Dominic Ffytche, Dag Aarsland, K. Ray Chaudhuri, Clive Ballard, Jee-Young Lee, Yu Kyeong Kim, Latha Velayudhan, Sagnik Bhattacharyya

Summary: This study conducted a meta-analysis of MRI studies to explore the neuroanatomical alterations underlying psychosis in Parkinson's Disease (PDP). The results revealed widespread grey matter volume loss in the parieto-temporo-occipital regions of PDP patients, which was associated with the expression of serotonergic receptor genes (5-HT1a and 5-HT2a), but not dopaminergic receptors.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2023)

Article Clinical Neurology

Differential response to donepezil in MRI subtypes of mild cognitive impairment

Patricia Diaz-Galvan, Giulia Lorenzon, Rosaleena Mohanty, Gustav Martensson, Enrica Cavedo, Simone Lista, Andrea Vergallo, Kejal Kantarci, Harald Hampel, Bruno Dubois, Michel J. Grothe, Daniel Ferreira, Eric Westman

Summary: This study investigated the differential response of mild cognitive impaired (MCI) individuals with different magnetic resonance imaging (MRI) subtypes to donepezil treatment. Results showed that only MCI patients with minimal atrophy or hippocampal-sparing subtypes benefited from donepezil, as the drug slowed down the atrophy rate in these subtypes. The continuous subtyping approach, rather than the conventional categorical approach, captured this differential response.

ALZHEIMERS RESEARCH & THERAPY (2023)

Article Clinical Neurology

Associations between different tau-PET patterns and longitudinal atrophy in the Alzheimer's disease continuum: biological and methodological perspectives from disease heterogeneity

Rosaleena Mohanty, Daniel Ferreira, Agneta Nordberg, Eric Westman

Summary: This study investigated the relationship between tau pathology and atrophy in Alzheimer's disease (AD) using tau-PET and structural MRI. The results showed that tau-PET patterns were associated with longitudinal atrophy in the AD continuum. Heterogeneity was also characterized as a continuous phenomenon, offering new insights into disease progression.

ALZHEIMERS RESEARCH & THERAPY (2023)

Article Clinical Neurology

Cognitive and Motor Decline in Dementia with Lewy Bodies and Parkinson's Disease Dementia

Maria Camila Gonzalez, Diego Alejandro Tovar-Rios, Guido Alves, Ingvild Dalen, Caroline H. Williams-Gray, Marta Camacho, Lars Forsgren, David Backstrom, Rachael A. Lawson, Angus D. Macleod, Carl E. Counsell, Claire Paquet, Carlo DeLena, Fabrizia D'Antonio, Andrea Pilotto, Alessandro Padovani, Frederic Blanc, Cristian Falup-Pecurariu, Simon J. G. Lewis, Konrad Rejdak, Ewa Papuc, Jakub Hort, Zuzana Nedelska, John O'Brien, Laura Bonanni, Marta Marquie, Merce Boada, Vanesa Pytel, Carla Abdelnour, Daniel Alcolea, Katrin Beyer, Ole-Bjorn Tysnes, Dag Aarsland, Jodi Maple-Grodem

Summary: This study compares the rate of cognitive and motor decline in patients with DLB and PDD, finding that both disorders show similar rates of decline. This has implications for future clinical trial designs.

MOVEMENT DISORDERS CLINICAL PRACTICE (2023)

Review Clinical Neurology

Should continuous dopaminergic stimulation be a standard of care in advanced Parkinson's disease?

Z. Pirtosek, V. Leta, P. Jenner, M. Verin

Summary: The standard of care refers to the level of care and treatment that healthcare providers should offer to patients, based on scientific evidence and medical knowledge. In the case of Parkinson's disease, the standard care is typically oral treatment with dopaminergic drugs. However, during the later stages of the disease, effective management with levodopa becomes more challenging, leading to the emergence of infusion therapies.

JOURNAL OF NEURAL TRANSMISSION (2023)

Article Geriatrics & Gerontology

Biomarkers of Alzheimer's Disease and Cerebrovascular Disease in Relation to Depressive Symptomatology in Individuals With Subjective Cognitive Decline

Mariola Zapater-Fajari, Patricia Diaz-Galvan, Nira Cedres, Therese Rydberg Sterner, Lina Ryden, Simona Sacuiu, Margda Waern, Anna Zettergren, Henrik Zetterberg, Kaj Blennow, Silke Kern, Vanesa Hidalgo, Alicia Salvador, Eric Westman, Ingmar Skoog, Daniel Ferreira

Summary: This study found a significant association between depressive symptomatology and SCD-memory and SCD-concentration. Depressive symptomatology was not associated with AD and CVD biomarkers. The phosphorylated tau biomarker and depressive symptomatology predicted SCD-memory, while the A beta 42/40 ratio and depressive symptomatology predicted SCD-concentration.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2023)

Article Geriatrics & Gerontology

Comparing three neuropsychological subgrouping approaches in subjective and mild cognitive impairment from a naturalistic multicenter study

Anna Rennie, Urban Ekman, John Wallert, J-Sebastian Muehlboeck, Maria Eriksdotter, Lars-Olof Wahlund, Daniel Ferreira, Eric Westman

Summary: This study compared three different approaches to subgroup SCI and MCI patients and investigated their capacity to disentangle cognitive and biomarker heterogeneity. The three approaches identified individuals with different biomarkers and captured some neuropsychological differences. The study helps advance understanding of the clinical and biological heterogeneity within SCI and MCI.

NEUROBIOLOGY OF AGING (2023)

暂无数据